Pooled analysis reveals semaglutide shows good efficacy in older adults aged over 65 years
A new analysis of the STEP trials carried out by semaglutide manufacturer Novo Nordisk has analyzed various trials to show the safety and efficacy of the obesity drug semaglutide in older adults (over 65 years), and found similar efficacy and safety as in the general trial populations. The study is
ORIGINAL SOURCE →via Medical Xpress
ADVERTISEMENT
⚡ STAY AHEAD
Events like this, convergence-verified across 689 sources, land in your inbox every Sunday. Free.
GET THE SUNDAY BRIEFING →RELATED · conflict
- [CONFLICT] Intermodal Asia
- [CONFLICT] UNDRR Regional Office for Arab States
- [CONFLICT] Digital security in war and conflict: challenges for civil society and tools for resilience
- [CONFLICT] Securing the Untrusted Agentic Development Layer
- [CONFLICT] War with Iran not over, enriched uranium needs to be removed, Netanyahu tells 60 Minutes
- [CONFLICT] Hatay’da göçmen kaçakçılığı; 1 tutuklama